contact@starkagetx.com

Our Company
- Senior Management
- Scientific Advisory Board
Our Approach
News
Contact

Category Archives: Articles

HomeStarkAge Therapeutics – Articles

Dipeptidyl Peptidase 4 (DPP4) as a new convincing target to eliminate cancer and senescent cancer cells

7 juillet 20257 juillet 2025Articles

Dipeptidyl peptidase 4 (DPP4) as a new senescence-associated target to eliminate cancer cells

7 juillet 20257 juillet 2025Articles

NewsLetter #6

27 novembre 202427 novembre 2024Articles

StarkAge Therapeutics at AACR 2024 (San Diego)

27 mai 202427 mai 2024Articles

StarkAge Therapeutics present their most recent findings at ICSA 2022

9 octobre 20229 octobre 2022Articles

Categories

Articles (6)
Press release (6)

Recent Posts

7 juillet 2025Dipeptidyl Peptidase 4 (DPP4) as a new convincing target to eliminate cancer and senescent cancer cells
7 juillet 2025Dipeptidyl peptidase 4 (DPP4) as a new senescence-associated target to eliminate cancer cells
19 juin 2025StarkAge Therapeutics Awarded Winner of the 2024 I-Nov Innovation Competition Organized by Bpifrance
27 novembre 2024NewsLetter #6

Click here to be updated on news from StarkAge Therapeutics

Address

Campus de l’Institut Pasteur Lille

1 Rue du Professeur Calmette

59800 Lille

Email Us

contact@starkagetx.com

StarkAge Therapeutics © 2022 - All Rights Reserved

About | We are Hiring | Legal | Privacy Policy | Cookies